[
    [
        {
            "time": "2021-03-01",
            "original_text": "恒瑞医药今日大宗交易成交11万股，成交价88.0元折价4.44%。",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "折价"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药今日大宗交易成交11万股，成交价88.0元折价4.44%。",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "高瓴资本概念股近三日受39亿主力资金追捧。",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "主力资金",
                    "追捧"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股近三日受39亿主力资金追捧。",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "蓝月亮2020年报解读，兼谈“龙头溢价”和消费品公司的增长动力。",
            "features": {
                "keywords": [
                    "蓝月亮",
                    "年报",
                    "龙头溢价",
                    "增长动力"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "蓝月亮2020年报解读，兼谈“龙头溢价”和消费品公司的增长动力。",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "疾病控制率超95%！璎黎药业PI3Kδ抑制剂2期注册临床结果公布。",
            "features": {
                "keywords": [
                    "璎黎药业",
                    "PI3Kδ抑制剂",
                    "临床结果",
                    "疾病控制率"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疾病控制率超95%！璎黎药业PI3Kδ抑制剂2期注册临床结果公布。",
                "Correlation": 9,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "A股融资融券日报：两融余额增加14.28亿元（3月30日）。",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "增加"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加14.28亿元（3月30日）。",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "结合板块走势，甄选Q1业绩高增长个股——医药行业月报 ——中性。",
            "features": {
                "keywords": [
                    "医药",
                    "板块走势",
                    "Q1业绩",
                    "高增长"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "结合板块走势，甄选Q1业绩高增长个股——医药行业月报 ——中性。",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "2020江苏省创新型百强企业排第三！恒瑞医药创新能力再获肯定。",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "创新能力",
                    "百强企业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2020江苏省创新型百强企业排第三！恒瑞医药创新能力再获肯定。",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]